Business

Charges

U.S. Atty. Preet Bharara in New York announces insider-trading charges against former hedge fund manager Mathew Martoma for an alleged scheme to profit from clinical trial results for an Alzheimer's disease drug. Stan Honda / AFP/Getty Images
Loading